Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine, Mlv, Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract
402 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
402
Total Reports
44
Deaths Reported
1090.0%
Death Rate
Active Ingredients
Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine, Mlv, Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract
Administration Routes
SubcutaneousParenteralUnknownOralSubconjunctivalOther
Species Affected
Dog 402
Most Affected Breeds
Retriever - Labrador 46
Shepherd Dog - Australian 30
Retriever - Golden 29
Chihuahua 24
Pit Bull 22
Shih Tzu 17
Dachshund (unspecified) 16
Shepherd Dog - German 13
Crossbred Canine/dog 10
Terrier - Yorkshire 9
Most Reported Reactions
Vomiting 113
Other abnormal test result NOS 62
Diarrhoea 52
Lethargy (see also Central nervous system depression in Neurological) 42
Lethargy (see also Central nervous system depression in 'Neurological') 40
Anaphylaxis 34
Lack of efficacy (virus) - parvovirus (including feline panleukopenia) 32
Death 26
Not eating 26
Facial swelling (see also 'Skin') 25
Leucocytosis NOS 25
Pale mucous membrane 23
Outcome Breakdown
Recovered/Normal
140 (34.8%)
Outcome Unknown
138 (34.3%)
Ongoing
78 (19.4%)
Died
27 (6.7%)
Euthanized
17 (4.2%)
Recovered with Sequela
2 (0.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.